[1] Elsberger B.Translational evidence on the role of Src kinase and activated Src kinase in invasive breast cancer[J].Crit Rev Oncol Hematol,2014,89(3):343-351.[2] Vyas A,Dandawate P,Padhye S,et al.Perspectives on new synthetic curcumin analogs and their potential anticancer properties[J].Curr Pharm Design,2013,19(11):2047-2069.[3] Nagalingam A,Kuppusamy P,Singh SV,et al.Mechanistic elucidation of the antitumor properties of withaferin A in breast cancer[J].Cancer Res,2014,74(9):2617-2629.[4] 刘 力,刘国文,谭米多.乳腺癌的综合治疗现状[J].中国肿瘤外科杂志,2013,5(1):60-63.[5] LeeJA,Bae JW,Woo SU,et al.Correlation between Cox-2 expression and hormone receptors in invasive ductal breast cancer[J].J Korean Surg Soc,2010,78(3):140-148.[6] Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.[7] Downs-Holmes C,Silverman P.Breast cancer:overview & updates[J].Nurse Pract,2011,36(12):20-26.[8] Ristimaki A,Sivula A,Lundin J,et al.Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer[J].Cancer Res,2002,62(3):632-635.[9] Holmes MD,Chen WY,Schnitt SJ,et al.COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin[J].Breast Cancer Res Treat, 2011,130(2):657-662.[10] Denkert C,Winzer KJ,Hauptmann S.Prognostic impact of cyclooxygenase-2 in breast cancer[J].Clin Breast Cancer,2004,4(6):428-433.[11] Qin G,Xu F,Qin T,et,al.Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/Cox-2 signaling pathway [J].Oncotarget,2015,6(39):41794-41808.[12] Singh B,Irving LR,Tai K,et al.Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines[J].J Surg Res,2010,163(2):235-243.[13] Cory S,Adams JM.Killing cancer cells by flipping the Bcl-2/ Bax switch[J].Cancer Cell,2005,8(1):5-6.[14] 赵明哲,刘靖华,李玉花,等.ERK信号通路的信号转导调控机制[J].国际病理科学与临床杂志,2009,29(1):15-19.[15] Santen RJ,Song RX,McPherson R,etal.The role of mitogen-activated protein (MAP) kinase in breast cancer [J].J Steroid Biochem Mol Biol,2002,80(2):239-256.[16] 张 莹,李春艳,崔泽实,等.TSG101与HIF-1α在乳腺癌组织中的表达及意义[J].中国实用内科杂志,2014,34(Suppl1):96-98. |